ScholarLens Back to search
2012•Journal of Modern Clinical MedicineRequires access

Study of Shengxueningpian with Different Dose in Treatment of Adults' Iron Deficiency Anemia

Tao Yang

Open publisher page 0 citations

Abstract

Objective:To study the efficacy of Shengxueningpian with different dose in treatment of adults' iron deficiency anemia.Methods:50 patients were divided to receive Shengxueningpian 0.5 tid or 0.5 bid for 4 weeks.Results:A total effective rate was 92.00% in Shengxueningpian 0.5 tid group and 80.00% in Shengxueningpian 0.5 bid group.The difference of two groups was not statistically significant.The drug had not significant adverse reactions.Conclusion:Result of this study suggest that Shengxueningpian be an effective and safe agent for treatment of iron deficiency anemia.

About this research paper

What this paper is about

Objective:To study the efficacy of Shengxueningpian with different dose in treatment of adults' iron deficiency anemia.Methods:50 patients were divided to receive Shengxueningpian 0.5 tid or 0.5 bid for 4 weeks.Results:A total effective rate was 92.00% in Shengxueningpian 0.5 tid group and 80.00% in Shengxueningpian 0.5 bid group.The difference of two groups was not statistically significant.The drug had not significant adverse reactions.Conclusion:Result of this study suggest that Shengxueningpian be an effective and safe agent for treatment of iron deficiency anemia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the efficacy of Shengxueningpian with different dose in treatment of adults' iron deficiency anemia.Methods:50 patients were divided to receive Shengxueningpian 0.5 tid or 0.5 bid for 4 weeks.Results:A total effective rate was 92.00% in Shengxueningpian 0.5 tid group and 80.00% in Shengxueningpian 0.5 bid group.The difference of two groups was not statistically significant.The drug had not significant adverse reactions.Conclusion:Result of this study suggest that Shengxueningpian be an effective and safe agent for treatment of iron deficiency anemia.

Key concepts: Medicine, Anemia, Iron-deficiency anemia, Iron deficiency, Adverse effect, Significant difference, Internal medicine, Drug reaction

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Study of Shengxueningpian with Different Dose in Treatment of Adults' Iron Deficiency Anemia — Research Paper | ScholarLens